Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition-Reference-Cited by-同舟云学术

Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition

Published:2020-03-05 Issue:7 Volume:59 Page:701-712
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Mitchell Elizabeth¹,Jindal Sonali¹²,Chan Tiffany¹,Narasimhan Jayasri¹,Sivagnanam Shamilene³,Gray Elliot⁴,Chang Young Hwan⁴,Weinmann Sheila⁵,Schedin Pepper¹²^ORCID

Affiliation:

1. Department of Cell, Developmental, and Cancer BiologyOregon Health and Science University Portland Oregon

2. Cancer Prevention and Control, Knight Cancer InstituteOregon Health and Science University Portland Oregon

3. Computational Biology Program, Department of Cell, Developmental, and Cancer BiologyOregon Health and Science University Portland Oregon

4. Department of Biomedical Engineering, Oregon Center for Spatial Systems BiomedicineOregon Health and Science University Portland Oregon

5. Center for Health ResearchKaiser Permanente Northwest Portland Oregon

Funder

Susan G. Komen

Oregon Clinical and Translational Research Institute

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23171

Reference68 articles.

1. Cancer statistics: Breast cancer in situ

2. Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up

3. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

4. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance;Signal Transduction and Targeted Therapy;2024-04-03

2. Isogenic Mammary Models of Intraductal Carcinoma Reveal Progression to Invasiveness in the Absence of a Non-Obligatory In Situ Stage;Cancers;2023-04-12

3. Neurotrophin signaling is a central mechanism of salivary dysfunction after irradiation that disrupts myoepithelial cells;npj Regenerative Medicine;2023-03-25

4. TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression;npj Breast Cancer;2023-03-02

5. Re-evaluation of the myoepithelial cells roles in the breast cancer progression;Cancer Cell International;2022-12-12